Kedrion Biopharma is a global biopharmaceutical company that specializes in plasma-derived therapies for rare diseases such as Hemophilia and Primary Immune Deficiencies, providing vital support to individuals suffering from these conditions.
With a profound sense of responsibility, Kedrion Biopharma is privileged to offer exclusive distribution rights for KEDRAB in the US since 2018, and actively supports patients associations worldwide to improve the lives of those affected by immunodeficiency disorders.
Generated from the website